Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2019 3
2020 4
2021 8
2022 3
2023 1
2025 10
2026 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
Cannabis and cannabidiol (CBD) for the treatment of fibromyalgia.
Berger AA, Keefe J, Winnick A, Gilbert E, Eskander JP, Yazdi C, Kaye AD, Viswanath O, Urits I. Berger AA, et al. Best Pract Res Clin Anaesthesiol. 2020 Sep;34(3):617-631. doi: 10.1016/j.bpa.2020.08.010. Epub 2020 Aug 15. Best Pract Res Clin Anaesthesiol. 2020. PMID: 33004171 Review.
Fibromyalgia is a complex disease process that is as prevalent as it is poorly understood. ...Evidence supporting the use of cannabis in chronic pain and specifically in fibromyalgia is being gathered as the use of cannabis increases with current global trends. ...
Fibromyalgia is a complex disease process that is as prevalent as it is poorly understood. ...Evidence supporting the use of cannabis …
An experimental randomized study on the analgesic effects of pharmaceutical-grade cannabis in chronic pain patients with fibromyalgia.
van de Donk T, Niesters M, Kowal MA, Olofsen E, Dahan A, van Velzen M. van de Donk T, et al. Pain. 2019 Apr;160(4):860-869. doi: 10.1097/j.pain.0000000000001464. Pain. 2019. PMID: 30585986 Free PMC article. Clinical Trial.
In this experimental randomized placebo-controlled 4-way crossover trial, we explored the analgesic effects of inhaled pharmaceutical-grade cannabis in 20 chronic pain patients with fibromyalgia. We tested 4 different cannabis varieties with exact knowledge on their [INCRE …
In this experimental randomized placebo-controlled 4-way crossover trial, we explored the analgesic effects of inhaled pharmaceutical-grade …
Ingestion of a THC-Rich Cannabis Oil in People with Fibromyalgia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Chaves C, Bittencourt PCT, Pelegrini A. Chaves C, et al. Pain Med. 2020 Oct 1;21(10):2212-2218. doi: 10.1093/pm/pnaa303. Pain Med. 2020. PMID: 33118602 Free PMC article. Clinical Trial.
OBJECTIVE: To determine the benefit of a tetrahydrocannabinol (THC)-rich cannabis oil on symptoms and quality of life of fibromyalgia patients. METHODS: A double-blind, randomized, placebo-controlled clinical trial was conducted for eight weeks to determine the benefit of …
OBJECTIVE: To determine the benefit of a tetrahydrocannabinol (THC)-rich cannabis oil on symptoms and quality of life of fibromyalgia …
Cannabis-based medicines for chronic neuropathic pain in adults.
Mücke M, Phillips T, Radbruch L, Petzke F, Häuser W. Mücke M, et al. Cochrane Database Syst Rev. 2018 Mar 7;3(3):CD012182. doi: 10.1002/14651858.CD012182.pub2. Cochrane Database Syst Rev. 2018. Update in: Cochrane Database Syst Rev. 2026 Jan 19;1:CD012182. doi: 10.1002/14651858.CD012182.pub3. PMID: 29513392 Free PMC article. Updated.
The studies were 2 to 26 weeks long and compared an oromucosal spray with a plant-derived combination of tetrahydrocannabinol (THC) and cannabidiol (CBD) (10 studies), a synthetic cannabinoid mimicking THC (nabilone) (two studies), inhaled herbal cannabis (two studies) and …
The studies were 2 to 26 weeks long and compared an oromucosal spray with a plant-derived combination of tetrahydrocannabinol (THC) and cann …
Chronic Pain Syndromes in Women.
Muchowski K. Muchowski K. Prim Care. 2025 Jun;52(2):329-340. doi: 10.1016/j.pop.2025.01.006. Epub 2025 Mar 10. Prim Care. 2025. PMID: 40412910 Review.
Chronic pain syndromes like fibromyalgia, chronic pelvic pain, interstitial cystitis/bladder pain syndrome, and chronic migraine cause significant disability and impair quality of life for many women. ...
Chronic pain syndromes like fibromyalgia, chronic pelvic pain, interstitial cystitis/bladder pain syndrome, and chronic migraine caus …
Cannabidiol versus placebo in patients with fibromyalgia: a randomised, double-blind, placebo-controlled, parallel-group, single-centre trial.
Rasmussen MU, Christensen R, Wæhrens EE, Henriksen M, Duhn PH, Bliddal H, Amris K. Rasmussen MU, et al. Ann Rheum Dis. 2026 Mar;85(3):566-574. doi: 10.1016/j.ard.2025.07.008. Epub 2025 Aug 22. Ann Rheum Dis. 2026. PMID: 40846590 Clinical Trial.
OBJECTIVES: Cannabidiol (CBD) is used to alleviate fibromyalgia pain despite limited evidence for efficacy. This study assessed the efficacy and safety of CBD vs placebo in patients with fibromyalgia, hypothesising that CBD would be superior to …
OBJECTIVES: Cannabidiol (CBD) is used to alleviate fibromyalgia pain despite limited evidence for efficacy. This study assesse …
Feasibility, Safety and Preliminary Efficacy of 1:1 THC:CBD Cannabis Oil for Fibromyalgia Symptoms: Results From a Randomised, Double-Blind, Placebo-Controlled Pilot Trial.
Kurlyandchik I, Tiralongo E, Lauche R, Tracey G, Ng J, Schloss J. Kurlyandchik I, et al. Pain Res Manag. 2026;2026(1):e7311235. doi: 10.1155/prm/7311235. Pain Res Manag. 2026. PMID: 42142029 Free PMC article. Clinical Trial.
Fibromyalgia is a chronic disorder characterised by widespread pain and other symptoms that substantially impact the quality of life. This double-blind, randomised, placebo-controlled trial primarily assessed feasibility (procedures and intervention adherence) and safety/t …
Fibromyalgia is a chronic disorder characterised by widespread pain and other symptoms that substantially impact the quality of life. …
Cannabinoids in Chronic Pain: Clinical Outcomes, Adverse Effects and Legal Challenges.
Sic A, George C, Gonzalez DF, Tseriotis VS, Knezevic NN. Sic A, et al. Neurol Int. 2025 Sep 5;17(9):141. doi: 10.3390/neurolint17090141. Neurol Int. 2025. PMID: 41002929 Free PMC article. Review.
Quantitative data show that discontinuation rates range from 4.3% at low-dose CBD to 12.9% at high-dose CBD, compared with 3.5% on placebo, while nabiximols (THC + CBD spray) are associated with dizziness in 25% of patients, somnolence in 8%, and treatment di …
Quantitative data show that discontinuation rates range from 4.3% at low-dose CBD to 12.9% at high-dose CBD, compared with 3.5 …
Cannabidiol Product Dosing and Decision-Making in a National Survey of Individuals with Fibromyalgia.
Boehnke KF, Gagnier JJ, Matallana L, Williams DA. Boehnke KF, et al. J Pain. 2022 Jan;23(1):45-54. doi: 10.1016/j.jpain.2021.06.007. Epub 2021 Jun 30. J Pain. 2022. PMID: 34214700 Free PMC article.
Many people with fibromyalgia use cannabidiol (CBD) products despite limited rigorous evidence of benefit. ...Our granular investigation reveals variability of CBD product dosing practices for fibromyalgia, and how past-year HTC use influences CBD …
Many people with fibromyalgia use cannabidiol (CBD) products despite limited rigorous evidence of benefit. ...Our granular inv …
Pilot Study of Cannabidiol for Treatment of Aromatase Inhibitor-Associated Musculoskeletal Symptoms in Breast Cancer.
Fleege NMG, Miller EA, Kidwell KM, Zacharias ZR, Houtman J, Scheu K, Kemmer K, Boehnke KF, Henry NL. Fleege NMG, et al. Cancer Med. 2025 Aug;14(15):e71117. doi: 10.1002/cam4.71117. Cancer Med. 2025. PMID: 40751295 Free PMC article. Clinical Trial.
AIMSS is due in part to systemic inflammation. Cannabidiol (CBD) has anti-nociceptive and anti-inflammatory properties, making it a potential treatment option for AIMSS. ...Additional studies are needed to further understand the impact of CBD on AIMSS and which pati …
AIMSS is due in part to systemic inflammation. Cannabidiol (CBD) has anti-nociceptive and anti-inflammatory properties, making it a p …
29 results